Literature DB >> 32800192

Computerized Chest Imaging in the Diagnosis and Assessment of the Patient with Chronic Obstructive Pulmonary Disease.

Carrie L Pistenmaa1, George R Washko2.   

Abstract

Computerized tomography in chronic obstructive pulmonary disease (COPD) has been the subject of intense interest in the research and clinical community. Methods have been developed to objectively detect and quantify processes affecting the lung parenchyma, airways and vasculature, as well as extrapulmonary manifestations of the noxious effects of chronic inhalational exposures, such as tobacco smoke. This article provides a brief overview of image-based advances in COPD research and then discusses how these advances have translated to clinical care, finishing with a brief description of a path forward for the convergence of research and care at the bedside.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chronic obstructive pulmonary disease; Comorbidity; Computed tomography; Imaging; Lung; Parenchyma; Vasculature

Mesh:

Year:  2020        PMID: 32800192      PMCID: PMC7454015          DOI: 10.1016/j.ccm.2020.06.012

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  31 in total

1.  Pathologic changes in the peripheral airways of young cigarette smokers.

Authors:  D E Niewoehner; J Kleinerman; D B Rice
Journal:  N Engl J Med       Date:  1974-10-10       Impact factor: 91.245

2.  Pulmonary arterial enlargement and acute exacerbations of COPD.

Authors:  J Michael Wells; George R Washko; MeiLan K Han; Naseer Abbas; Hrudaya Nath; A James Mamary; Elizabeth Regan; William C Bailey; Fernando J Martinez; Elizabeth Westfall; Terri H Beaty; Douglas Curran-Everett; Jeffrey L Curtis; John E Hokanson; David A Lynch; Barry J Make; James D Crapo; Edwin K Silverman; Russell P Bowler; Mark T Dransfield
Journal:  N Engl J Med       Date:  2012-09-03       Impact factor: 91.245

3.  Computed tomographic measurements of airway dimensions and emphysema in smokers. Correlation with lung function.

Authors:  Y Nakano; S Muro; H Sakai; T Hirai; K Chin; M Tsukino; K Nishimura; H Itoh; P D Paré; J C Hogg; M Mishima
Journal:  Am J Respir Crit Care Med       Date:  2000-09       Impact factor: 21.405

4.  Reduced Bone Density and Vertebral Fractures in Smokers. Men and COPD Patients at Increased Risk.

Authors:  Joshua D Jaramillo; Carla Wilson; Douglas S Stinson; Douglas J Stinson; David A Lynch; Russell P Bowler; Sharon Lutz; Jessica M Bon; Ben Arnold; Merry-Lynn N McDonald; George R Washko; Emily S Wan; Dawn L DeMeo; Marilyn G Foreman; Xavier Soler; Sarah E Lindsay; Nancy E Lane; Harry K Genant; Edwin K Silverman; John E Hokanson; Barry J Make; James D Crapo; Elizabeth A Regan
Journal:  Ann Am Thorac Soc       Date:  2015-05

5.  Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease.

Authors:  Karine Marquis; Richard Debigaré; Yves Lacasse; Pierre LeBlanc; Jean Jobin; Guy Carrier; François Maltais
Journal:  Am J Respir Crit Care Med       Date:  2002-09-15       Impact factor: 21.405

6.  Diagnosis of pulmonary emphysema by computerised tomography.

Authors:  M D Hayhurst; W MacNee; D C Flenley; D Wright; A McLean; D Lamb; A J Wightman; J Best
Journal:  Lancet       Date:  1984-08-11       Impact factor: 79.321

7.  A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema.

Authors:  Alfred Fishman; Fernando Martinez; Keith Naunheim; Steven Piantadosi; Robert Wise; Andrew Ries; Gail Weinmann; Douglas E Wood
Journal:  N Engl J Med       Date:  2003-05-20       Impact factor: 91.245

8.  Lung volumes and emphysema in smokers with interstitial lung abnormalities.

Authors:  George R Washko; Gary M Hunninghake; Isis E Fernandez; Mizuki Nishino; Yuka Okajima; Tsuneo Yamashiro; James C Ross; Raúl San José Estépar; David A Lynch; John M Brehm; Katherine P Andriole; Alejandro A Diaz; Ramin Khorasani; Katherine D'Aco; Frank C Sciurba; Edwin K Silverman; Hiroto Hatabu; Ivan O Rosas
Journal:  N Engl J Med       Date:  2011-03-10       Impact factor: 91.245

9.  Computed tomography-based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progression.

Authors:  Craig J Galbán; Meilan K Han; Jennifer L Boes; Komal A Chughtai; Charles R Meyer; Timothy D Johnson; Stefanie Galbán; Alnawaz Rehemtulla; Ella A Kazerooni; Fernando J Martinez; Brian D Ross
Journal:  Nat Med       Date:  2012-10-07       Impact factor: 53.440

10.  Detection of emphysema progression in alpha 1-antitrypsin deficiency using CT densitometry; methodological advances.

Authors:  David G Parr; Martin Sevenoaks; Chunqin Deng; Berend C Stoel; Robert A Stockley
Journal:  Respir Res       Date:  2008-02-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.